trial

Familial Schizophrenia and Spectrum Personality Disorders

NCTId NCT00666146
as of 2026-07-01
at a glance
Phase — · Completed
Enrollment 539 (actual)
Primary completion 2020-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Completed
Enrollment
539 (actual)
Study type
Observational
Allocation
Model
Masking
Start
2004-07
Primary completion
2020-01
Eligibility
ALL · 16 Years · 58 Years

Interventions & indications

Drugs

Sponsors

Investigators

1
James Levitt, M.D.Principal Investigator

Sites

3 total
Baltimore, United StatesBaltimore, United StatesCatonsville, United States

Facts & assertions

4 sourced
Enrollment
539
Phase
NA
Primary Completion Date
2020-01
Status
COMPLETED
relationships
The graph out of here
indication
indication
indication
investigator